Form 4: United Therapeutics Director Tommy G. Thompson Executes Stock Option and Sells Shares
SEC Form 4 Filing
Director Tommy G. Thompson exercised stock options and sold shares of United Therapeutics Corp on March 24, 2025.
Summary
- On March 24, 2025, Tommy G. Thompson, a director of United Therapeutics Corporation, exercised stock options to acquire 2,500 shares of common stock at a price of $175.43 per share.
- Simultaneously, Thompson sold 2,500 shares of common stock at a weighted average price of $318.7962, with individual trades ranging from $318.43 to $319.21.
- Following these transactions, Thompson directly owns 8,480 shares of common stock and indirectly owns 8,200 shares through a trust and 5,800 shares through a family LLC.
- The exercised stock options were granted on June 26, 2016, and were set to expire on June 26, 2025.
Sentiment
Score: 5
Explanation: Neutral sentiment as it reflects routine insider trading activity.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the actions of company directors.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but are unlikely to be significant.
Key Dates
| Date | Description |
|---|---|
| 06/26/2016 | Date the stock options were granted. |
| 07/07/2023 | Date of RSU vesting for which the reporting person elected to defer receipt of shares. |
| 03/24/2025 | Date of stock option exercise and share sale. |
| 03/25/2025 | Date of signature on the Form 4 filing. |
| 06/26/2025 | Expiration date of the stock options. |
| 07/08/2026 | Date of common stock issuance as a result of the July 7, 2023 vesting of RSUs. |
Keywords
United Therapeutics, Director, Stock Options, Share Sale, Form 4, Beneficial Ownership, UTHR, Tommy G. Thompson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.